C. Arvanitis

发表

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

I. Pichot, C. Arvanitis, Sean M. Hartig, 2010, Cancer research.

Developmental Context Determines Latency of MYC-Induced Tumorigenesis

Robert D Cardiff, Anders Zetterberg, Rebecca A. Ihrie, 2004, PLoS biology.

18F and 18FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation

Sanjiv Sam Gambhir, C. Arvanitis, S. Gambhir, 2008, Cancer biology & therapy.

Combining virotherapy and angiotherapy for the treatment of breast cancer

A. Harris, C. Arvanitis, R. Sainson, 2013, Cancer Gene Therapy.

Protocol for live enhanced resolution confocal imaging of dendritic spinule dynamics in primary mouse cortical neuron culture

C. Arvanitis, P. Penzes, Sehyoun Yoon, 2021, STAR protocols.

Acyloxyacyl hydrolase regulates microglia-mediated pelvic pain

D. Winter, C. Arvanitis, A. Schaeffer, 2022, PloS one.

Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis

Debashis Sahoo, David L. Dill, Dean W. Felsher, 2008, PLoS genetics.

Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

Kenneth Chu, W. Dewey, C. Arvanitis, 2002, Science.

EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling

C. Arvanitis, M. Stepp, R. Lavker, 2018, Investigative ophthalmology & visual science.

Proximity Ligation Assay for Detecting Protein‐Protein Interactions and Protein Modifications in Cells and Tissues in Situ

C. Arvanitis, E. Sprecher, L. Godsel, 2020, Current protocols in cell biology.

Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

C. Arvanitis, D. Felsher, Dean W Felsher, 2006, Seminars in cancer biology.

Oncogenes and the Initiation and Maintenance of Tumorigenesis

C. Arvanitis, D. Felsher, P. Bachireddy, 2017 .

Identifying critical signaling molecules for the treatment of cancer.

C. Arvanitis, D. Felsher, P. Bachireddy, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Correction: Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis

D. Sahoo, D. Dill, C. Arvanitis, 2013, PLoS Genetics.

A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids.

C. Arvanitis, L. Platanias, A. Alvarez, 2016, BioTechniques.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Christopher H. Contag, Stefanie Mandl, Dean W. Felsher, 2004, Nature.

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells

C. Arvanitis, J. Frost, S. Corey, 2009, British Journal of Cancer.

Structure and Biomechanics of the Endothelial Transcellular Circumferential Invasion Array in Tumor Invasion

C. Arvanitis, K. Ridge, T. Chew, 2014, PloS one.

Conditionally MYC: insights from novel transgenic models.

C. Arvanitis, D. Felsher, Constadina Arvanitis, 2005, Cancer letters.

Cornea EphA 2 / Ephrin-A 1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM 10 Regulation of EGFR Signaling

C. Arvanitis, M. Stepp, R. Lavker, 2018 .

Cancer esearch oenvironment and Immunology 42-Interacting Protein 4 Promotes Breast Cancer Cell sion and Formation of Invadopodia through R ivation of N-WASp

I. Pichot, C. Arvanitis, Sean M. Hartig, 2010 .